Document:

EXHIBIT 10.31

     

    STRINGER
SAUL

    

    DATED
19th June
2007

    

    (1)           PROPHARMA
PARTNERS LIMITED

    

    and

     

    (2)           MEDGENICS,
INC.

     

    and

     

    (3)           MEDGENICS
MEDICAL ISRAEL, LTD.

    
 

    
      
 

    AGREEMENT

     

      
        

      

    

    

    17
Hanover Square London W1S 1HU

    Tel: 020
7917 8500 Fax: 020 7917 8555

    
      
         

      

      
        
        

        
          

        

      

      
         

      

    

    THIS AGREEMENT is made the 19th day of
June 2007

    

    BETWEEN:

    

    
      	
              (1)

            	
              PROPHARMA PARTNERS LIMITED a company
      incorporated pursuant to the laws of England and Wales and having its
      registered office at 5th Floor, Hanover Square, London W1S 1HU,
      United Kingdom (hereinafter referred to as “ProPharma”);
    and

            

    

    

    
      	
              (2)

            	
              MEDGENICS, INC. a company having a place
      of business at 8000 Towers Crescent Drive, Suite 1300, Vienna, VA 22182,
      USA and

            

    

    

    MEDGENICS MEDICAL ISRAEL, LTD. a company having
a place of business at Hanapach 12 Karmiel, Israel (hereinafter separately or
together referred to as “the Company”).

    

    WHEREAS:

    

    
      	
              A

            	
              ProPharma
      is engaged in the business of providing consultancy services to the
      pharmaceutical industry in relation to pharmaceutical products and has
      considerable skill, knowledge and experience in that
  field.

            

    

    

    
      	
              B

            	
              the
      Company wishes to engage ProPharma to carry out the Service (as defined
      below) and ProPharma has agreed to carry out the Service for the Company
      on the terms set forth below

            

    

    

    THE PARTIES AGREE as follows:

    

    
      	
              1

            	
              Definitions

            

    

    

    
      	
              1.1

            	
              In
      this agreement the following words and phrases shall have the respective
      following meanings except where the context requires
      otherwise:

            

    

    

    
      	
            	
              “Confidential
      Information”

            	
              means
      any information oral, visual or written that is disclosed, pursuant to
      this agreement, by the Company or its Affiliates to ProPharma or its
      Affiliates, employees, contractors or agents including but not limited to
      such information and data embodied in the Materials, the content of any
      report prepared, advice given or other work product produced hereunder,
      any other information generated in the course of provision of the Service
      and any information relating to The Company or its Affiliates and their
      products, designs, business operations, marketing plans, customer lists,
      pricing methods, personnel and organisational
  data;

            

    

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    
      	
            	
              “Consultancy
      Fee”

            	
              means
      that part of the Total Fee which is calculated in accordance with Schedule
      2;

            

    

    

    
      	
            	
              “Expenses”

            	
              means
      those travel, subsistence and other out-of-pocket expenses reasonably
      incurred by ProPharma in the provision of the
  Service;

            

    

    

    
      	
            	
              “Materials”

            	
              means
      all tangible materials made available by or on behalf of the Company to
      ProPharma in contemplation of or pursuant to this agreement or in the
      course of providing the Service;

            

    

    

    
      	
            	
              “Service”

            	
              means
      the advisory and consultancy services to be provided by ProPharma to the
      Company, full particulars of which are set out in Schedule 1 and the
      Appendix hereto;

            

    

    

    
      	
            	
              “Total
      Fee”

            	
              means
      the total consideration for the performance of the Service being the sum
      of the Consultancy Fee and the reimbursement of the
    Expenses.

            

    

    

    
      	
              1.2

            	
              The
      headings used are only for convenience and shall not affect interpretation
      of this agreement.

            

    

    

    
      	
              1.3

            	
              The
      terms of this agreement shall be deemed to include the provisions of the
      Schedules provided that in all respects the terms and conditions in the
      body of this agreement shall override any conflicting or amending
      provision contained in any Schedule or
  attachment.

            

    

    

    
      	
              1.4 

            	
              Reference
      to the singular shall include the plural and to masculine shall include
      feminine and vice versa.

            

    

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    
      	
              11 

            	
              Notices

            

    

    

    
      	
              11.1

            	
              Any
      notice given under or in connection with this agreement by either party to
      the other shall be in writing and shall be served by sending the same
      by registered post or recorded delivery or by leaving it at the address of
      the relevant party specified at the beginning of this agreement or at such
      other substitute address of which the parties may give notice from time to
      time in accordance with this
clause.

            

    

    

    
      	
              12 

            	
              Entire
      Agreement

            

    

    

    
      	
              12.1

            	
              This
      agreement (including the proposal set out in the Appendix hereto) contains
      the entire understanding and agreement of the parties with respect to the
      subject matter hereof and supersedes any prior representation or agreement
      written or oral. No amendment or waiver of any provision of this agreement
      or right arising therefrom shall be effective unless made in writing and
      agreed to in writing by an authorised signatory of each
    party.

            

    

    

    
      	
              12.2

            	
              If
      any provision of this agreement shall be declared illegal or void it shall
      be considered severed from this agreement without so far as possible
      affecting any other provision
hereof.

            

    

    

    
      	
              13 

            	
              Governing Law and
      Jurisdiction

            

    

    

    
      	
              13.1

            	
              This
      agreement is governed by and shall be construed in all respects with the
      laws of England and the parties hereby submit to the jurisdiction of the
      English courts.

            

    

    

    IN
WITNESS whereof, the parties have executed this agreement the day and year first
above written.

    

    
      
        
          
            
              
                
                  	
                          Signed
      by:

                        	
                          /s/ Peter J. Cozens

                        	 	
                          Signed
      by:

                        	
                          /s/ Andrew L. Pearlman

                        
	 	 	 	 	 
	
                          Name:

                        	
                          Peter J. Cozens

                        	 	
                          Name:

                        	
                          Andrew L. Pearlman

                        
	 	 	 	 	 
	
                          Position:

                        	
                          Principal

                        	 	
                          Position:

                        	
                          CEO

                        
	
                          duly
      authorised for and on behalf

                        	 	
                          duly
      authorised for and on behalf

                        
	
                          of PROPHARMA PARTNERS

                        	 	
                          of
      MEDGENICS, INC. and MEDGENICS

                        
	
                          LIMITED

                        	 	
                          MEDICAL
      ISRAEL,
LTD.

                        

                

              

            

          

        

      

    

     

    
      
         

      

      
        3EXHIBIT
10.32

     

    CONSULTING
SERVICES AGREEMENT

     

    This
agreement (“Agreement”) is entered into as of January 31st, 2008 Medgenics, Inc.
a corporation organized under the laws of Delaware (“Client”) and Biomondo
Consulting, Inc., a corporation organized under the laws of the State of
California (“Consultant”).

    WHEREAS,
Client wishes Consultant to perform the services described in Schedule A hereto
(“Services”), which shall be performed in accordance therewith and in accordance
with the terms hereof, and

    WHEREAS,
Consultant wishes to perform Services subject to the terms and conditions set
forth herein,

    NOW,
THEREFORE, the parties hereto agree as follows:

    

    ARTICLE
1

    Basic
Obligations of the Parties

     

    1.1 Services. Subject
to the terms and conditions provided for herein,

    (a)
Consultant, in consideration of the Contract Price (as defined in Section 2.1),
agrees to perform Services, and

    (b)
Client agrees to pay for Services as set forth in Section 2.1.

     

    1.2 Employees/Subcontractors. All
personnel assigned by Consultant to perform Services will be either employees of
Consultant or subcontractors with which Consultant has contracted and which have
been approved in advance by Client (“Subcontractors”). Consultant will pay all
salaries, fees and expenses of its employees and Subcontractors, and all
federal, social security, federal and state unemployment taxes, and any other
payroll or withholding taxes relating to its employees. Consultant (and its
Subcontractors) will be considered, for all purposes, an independent contractor,
and it will not, directly or indirectly, act as an agent, servant or employee of
Client, or make any commitments or incur any liabilities on behalf of Client
without its prior written consent.

    

    ARTICLE
2

    Terms of
Payment and Volumes

     

    2.1 Contract Price. In consideration for
performance of Services, Client shall make payment to Consultant for Services
rendered hereunder at the rates and in the amounts as in Schedule B hereto (the
“Contract Price”). The Contract Price includes all amounts to be paid by Client
under this Agreement, other than as specifically set forth herein, and shall be
payable as set forth in Schedule B hereto.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    2.2 Indemnity. Consultant shall
indemnify and hold harmless Client from and against any liability and costs,
including attorney fees, arising out of any failure to make payment to its
employees and its Subcontractors for Services rendered pursuant to this
Agreement.

    

    ARTICLE
3

    Term of
Agreement

     

    3.1 Term. This Agreement shall be
effective from the date hereof and shall terminate on completion of Phase 3, at
which time this Agreement shall terminate, unless otherwise renewed, extended,
or modified by a written agreement signed by both parties hereto; provided, however, that either party
shall have the right to terminate this Agreement prior to such date, at any time
upon not less than 30 days’ notice to the other party specifying the effective
date for termination.

     

    3.2 Survival of Certain Articles.
Consultant agrees that notwithstanding the termination of this Agreement
pursuant to Section 3.1 hereof, Section 2.2 and Articles 6, 8, and 9 shall
survive any such termination and remain in full force and effect.

     

    ARTICLE
4

    Risk of
Loss; Laws

     

    4.1 Risk. Consultant will provide for all
proper safeguards and shall assume all risks of loss to Consultant and its
employees and Subcontractors incurred in performing Services
hereunder.

     

    4.2 Laws. Consultant, its
employees and Subcontractors shall comply with all federal, state and local laws
and regulations applicable to the Services, including but not limited to laws
governing payment of its employees assigned to perform Services.

    

    ARTICLE
5

    Performance
of Services

     

    5.1 Conduct of Personnel. Without limiting
the responsibility of Consultant for the proper conduct of its personnel and
Subcontractors in the performance of Services, the conduct of the personnel
performing Services is to be guided by any rules and regulations as set forth in
a Schedule C hereto and any additional special written instructions as may be
agreed to by Client and Consultant.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    5.2 
Supervision. Consultant is responsible
for the direct management and supervision of its personnel and Subcontractors
through its designated representative, and such representative will, in turn, be
available at all reasonable times to report and confer with the designated
agents or representatives of Client with respect to Services being
rendered.

     

    5.3 
Qualifications and Removal. Consultant
agrees that Services to be provided will be performed by qualified, careful and
efficient employees or Subcontractors in strict conformity with the best
practices and highest applicable standards. Consultant further agrees that upon
request of Client it will remove from the performance of Services hereunder any
of its employees or Subcontractors who, in the reasonable opinion of Client, are
guilty of improper conduct or are not qualified to perform assigned
work.

    
 

    ARTICLE
6

    Confidential
Information

     

    6.1 Restriction. Consultant agrees not to
use or disclose to anyone, other than such disclosure to employees or
Subcontractors of Consultant as may be necessary to provide the Services, any
Confidential Information (as hereinafter defined). If requested by Client,
Consultant shall require its employees and Subcontractors performing Services
hereunder to execute confidentiality agreements prohibiting use or disclosure of
Confidential Information. For purposes of this Agreement, “Confidential
Information” is (a) information contained in any materials delivered to
Consultant pursuant to this Agreement and (b) information which relates to
Client’s technology, financial or business affairs, product development and
business plans and prospects or that of any of its customers or affiliates.
Consultant acknowledges that money damages would be both incalculable and an
insufficient remedy for any breach of this Article 6 by Consultant, its
employees or its Subcontractors and that any such breach would cause Client
irreparable harm. Accordingly, Consultant agrees that in the event of any breach
or threatened breach of this Article 6, Client shall be entitled, without the
requirement of posting a bond or other security, to equitable relief, including
injunctive relief and specific performance. Such remedy shall not be the
exclusive remedy for any breach of this letter agreement, but shall be in
addition to all other remedies available at law or equity to
Client.

     

    6.2 Delivery. Upon termination pursuant to
Article 3, Consultant shall deliver or cause to be delivered to Client all
Confidential Information and other material which has been prepared by
Consultant or its Subcontractors in connection with the performance of the
Services or in which Client has exclusive rights.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    ARTICLE
7

    Excuse
for Nonperformance

     

    7.1 Delays. Consultant’s obligation to
perform Services hereunder shall be excused without liability when prevented by
strike, act of God, governmental action, accident or any other condition beyond
its reasonable control. Consultant agrees to resume performance of Services as
soon as practicable following cessation of such condition.

     

    ARTICLE
8

    Disclaimer
of Consequential Damages

     

    8.1
Except in connection with a breach of the obligations under Article 6, neither
party shall not in any action or proceeding, or otherwise, assert any claim for
consequential, special or punitive damages against the other party (or the
party’s employees or agents) on account of any loss, cost, damage or expense
which the first party may suffer or incur because of any act or omission of the
second party.

     

    
    

    ARTICLE
9

    Hiring of
Employees/Subcontractors

     

    9.1 Client
agrees that, during the term of this Agreement and for one hundred eighty (180)
days immediately following the termination of this Agreement, it shall not,
directly or indirectly, hire any employees of Consultant or Subcontractors who
were employed by Consultant or provided Services at any time during the term of
this Agreement.

     

    9.2 Consultant
agrees that, during the term of this Agreement and for one hundred eighty (180)
days immediately following the termination of this Agreement, it shall not,
directly or indirectly, hire any employees of Client.

     

    
    

    ARTICLE
10

    General

     

    10.1 Assignment. This Agreement may not be
assigned by either party without the prior written consent of the other
party.

     

    10.2 Governing Law. This Agreement will be
governed in all respects by the law of the State of California.

     

    10.3 Amendment. This Agreement, including
the Schedules hereto, may be amended only by an instrument in writing executed
by the parties or their permitted assignees.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    10.4
Section Headings.
Section and Article headings are for reference purposes only and shall not
affect the interpretation or meaning of this Agreement.

     

    10.5 Notices. All notices pursuant
to this Agreement shall be in writing, except as provided herein. Notices in
writing shall be sufficient if hand delivered or mailed by first class mail,
postage prepaid, or sent by telecommunications to the attention of the person
listed below and to the party intended as the recipient thereof at the address
of such party set forth below, or at such other address or to the attention of
such other person as such party shall have designated for such purpose in a
written notice complying as to delivery with the terms of this
Section.

     

    
      
        
          	
                  Consultant:

                	
                  870
      Paseo Santa Cruz Thousand

                
	 
      	
                  Oaks,
      Ca 91320

                
	 
      	
                  Attn:
      Ray Chow, PhD

                
	 
      	
                  Medgenics,
      Inc.

                
	
                  Client:

                	
                  12
      Hanapach St, P.O. Box 6314

                
	 
      	
                  Karmiel,
      Israel 21653

                
	 
      	
                  Attn:
      Andrew Pearlman, MD

                

        

      

    

     

    10.6 No Waiver of Performance.
Failure by either party at any time to require performance by the other
party or to claim a breach of any provision of this Agreement will not be
construed as a waiver of any right accruing under this Agreement, nor affect any
subsequent breach, nor affect the effectiveness of this Agreement or any part
hereof, nor prejudice either party as regards any subsequent
action.

     

    10.7 Entire Agreement; Conflicting
Provisions. This Agreement together with the Schedules hereto constitutes
the entire agreement between Client and Consultant with respect to the subject
matter hereof and no representation or statement not contained in the main body
of this Agreement or such Schedules shall be binding upon Consultant or Client
as a warranty or otherwise. In the event of any conflict between the terms of
the main body of this Agreement and any of the Schedules hereto, the terms of
the main body of this Agreement shall govern.

     

    IN
WITNESS WHEREOF, the parties hereto have respectively caused this Agreement to
be executed by their duly authorized officers as of the day and year first
written above.

    

    
      
        
          
            
              
                	
                        CONSULTANT

                      
	 
      	 
      
	
                        By

                      	
                        /s/
      Ray Chow

                      
	 
      	
                        RAY
      CHOW

                      
	
                        Title:

                      	
                        PRESIDENT

                      

              

            

          

        

      

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      
        
          
            
              
                	
                        CLIENT

                      
	 
      	 
      
	
                        By

                      	
                        /s/
      Andrew Pearlman

                      
	
                        Title:

                      	
                        CEO

                      

              

            

          

        

      

    

    
    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    SCHEDULE
A Services

     

    Phase 1
Deliverable:

    A
PowerPoint Presentation (approximately 20 slides). A draft would be sent to you
in advance and then edits/refinement can be made subsequent to final
delivery.

     

    Purpose/Rationale:

    The
presentation will serve as a frame of reference and working document for
internal strategic discussions. It will incorporate existing company information
blended with addition strategic perspectives for consideration or dismissal. In
essence, it will allow the Board to align around a strategy, or strategies, and
proactively manipulate the choices the company will have to make in order to
maximize the chances for success. The successful future will be all about
simultaneous prediction and feedback.

     

    Phase 1.
There will be 4 components for the content to develop corporate strategy and the
strategic choices.

     

    Opportunity:

    1. List
of companies who may be interested in a platform technology including
rationale

    2. List
of companies and/or product(s) where Medgenics bio-pump technology may be ideal
for life cycle management. Regional Markets will be factored in as
appropriate.

    3. Medgenics
as a commercial entity. The US nephrology market will be used as the potential
example using Epodure. What would it take to be a serious commercial
player.

     

    Promise:

    1. What
Medgenics could deliver - therapeutically and by value.

    2. Conversely,
how Medgenics may be perceived by Pharma companies, particularly from a Business
Development perspective. This is to be a mini “pressure test” on your
assumptions and proof of concept from a business and NOT a scientific
perspective.

     

    Proof:

    1. A list
of the Medgenics’ assets from the perspective of an outsider, namely me. This in
turn will form the basis of the company storyboard for future business
development opportunities

     

    Conviction
and/or Exit Strategy:

    1. 
 What is the end in mind? What would be a successful outcome?

    The
presentation would be summarized with a series of action steps and
recommendations.

    
 

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
    

     

    SCHEDULE
B Contract Price

     

    Phase
1:      $20,000 (the “Phase 1 Fee”), plus reasonable
out-of-pocket expenses; provided, however, that all expenses in excess of $_____
individually, and $_____ in the aggregate, shall be approved in advance in
writing by Client. The Phase 1 Fee shall be payable only after delivery of the
PowerPoint Presentation described on Schedule A.

     

    Phase
2:      To be mutually agreed between Client and
Consultant

     

    Phase
3:      To be mutually agreed between Client and
Consultant

     

    Invoices
to be paid within 30 days of invoice date.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    SCHEDULE
C Rules of Engagement

     

    [Spell
out any special rules of conduct (e.g. compliance with security requirements of
Client’s customers)]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}]]